Adimmune Corporation (TPE:4142)
Taiwan · Delayed Price · Currency is TWD 18.50
-0.20 (-1.07%)
Apr 17, 2026, 1:30 PM CST
Adimmune Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -239.89 | -242.75 | -639.89 | 290.98 | 43.07 |
Depreciation & Amortization | 205.01 | 204.98 | 213.17 | 248.06 | 213.97 |
Other Amortization | 9.85 | 10.72 | 10.96 | 11.26 | 11.94 |
Loss (Gain) From Sale of Assets | -0.02 | -0.23 | 0.04 | -0.01 | -0.01 |
Stock-Based Compensation | 10.79 | 24.58 | 21.62 | 16.01 | 25.17 |
Provision & Write-off of Bad Debts | 38.02 | -0.15 | 393.88 | 4.92 | 0.07 |
Other Operating Activities | -97.76 | -75.23 | -128.34 | -133.41 | -83.51 |
Change in Accounts Receivable | 3.35 | 882.08 | -1,176 | -623.93 | -127.58 |
Change in Inventory | 56.91 | -101.59 | 132.92 | -153.45 | -203.83 |
Change in Accounts Payable | -14.47 | -11.16 | -6.46 | 43.2 | -17.58 |
Change in Unearned Revenue | 26.05 | -12.42 | 10.7 | -12.33 | -144.46 |
Change in Other Net Operating Assets | -3.3 | -10.35 | 274.95 | 16.75 | -197.76 |
Operating Cash Flow | -5.45 | 668.48 | -892.35 | -291.97 | -480.52 |
Capital Expenditures | -255.16 | -231.15 | -377.8 | -419.44 | -844.09 |
Sale of Property, Plant & Equipment | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 |
Sale (Purchase) of Intangibles | -0.25 | -1.03 | -1.04 | -0.19 | -1.17 |
Investment in Securities | 58.84 | -100.96 | 87.54 | 121.88 | 114.07 |
Other Investing Activities | -2.43 | 22.22 | -75.27 | -24.33 | 2.34 |
Investing Cash Flow | -198.98 | -310.9 | -366.56 | -322.07 | -728.84 |
Short-Term Debt Issued | 1,370 | 60 | 520 | 20 | - |
Long-Term Debt Issued | 588.56 | 6.11 | 544.9 | 898 | - |
Total Debt Issued | 1,959 | 66.11 | 1,065 | 918 | - |
Short-Term Debt Repaid | -1,545 | -100 | - | - | - |
Long-Term Debt Repaid | -201.06 | -543.11 | -188.34 | -64.05 | -11.14 |
Total Debt Repaid | -1,746 | -643.11 | -188.34 | -64.05 | -11.14 |
Net Debt Issued (Repaid) | 212.5 | -577 | 876.56 | 853.95 | -11.14 |
Repurchase of Common Stock | - | - | - | -292.54 | - |
Common Dividends Paid | - | - | - | - | -214.75 |
Other Financing Activities | -156.31 | 98.2 | -17.26 | 261.78 | 3 |
Financing Cash Flow | 56.19 | -478.8 | 859.3 | 823.19 | -222.89 |
Foreign Exchange Rate Adjustments | -9.9 | 8.34 | 0.03 | -4.1 | -3.2 |
Net Cash Flow | -158.13 | -112.88 | -399.58 | 205.07 | -1,435 |
Free Cash Flow | -260.61 | 437.34 | -1,270 | -711.4 | -1,325 |
Free Cash Flow Margin | -18.59% | 28.09% | -71.15% | -31.60% | -73.84% |
Free Cash Flow Per Share | -0.62 | 1.04 | -3.01 | -1.66 | -3.08 |
Cash Interest Paid | 38.97 | 35.18 | 31.22 | 20.23 | 14.68 |
Levered Free Cash Flow | -187.05 | 634.84 | -1,078 | -638.73 | -1,187 |
Unlevered Free Cash Flow | -167.57 | 657.64 | -1,057 | -624.61 | -1,178 |
Change in Working Capital | 68.55 | 746.56 | -763.77 | -729.77 | -691.21 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.